Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Isoxazoles | 7 | 2005 | 32 | 1.160 |
Why?
|
| Anesthesiologists | 2 | 2024 | 36 | 1.060 |
Why?
|
| Pain, Postoperative | 8 | 2005 | 257 | 1.000 |
Why?
|
| Foreign Medical Graduates | 1 | 2024 | 12 | 0.900 |
Why?
|
| Anesthesiology | 1 | 2024 | 93 | 0.800 |
Why?
|
| Morphine | 6 | 2005 | 90 | 0.740 |
Why?
|
| Cyclooxygenase Inhibitors | 5 | 2005 | 64 | 0.730 |
Why?
|
| Charities | 1 | 2020 | 2 | 0.710 |
Why?
|
| Ketorolac | 4 | 2004 | 17 | 0.680 |
Why?
|
| Thoracic Surgery | 1 | 2020 | 158 | 0.600 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2020 | 145 | 0.590 |
Why?
|
| Anesthesia | 1 | 2020 | 212 | 0.550 |
Why?
|
| Cardiac Catheterization | 1 | 2020 | 631 | 0.500 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 359 | 0.470 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 375 | 0.470 |
Why?
|
| Pandemics | 1 | 2020 | 1106 | 0.410 |
Why?
|
| Analgesics | 4 | 2004 | 134 | 0.370 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 4 | 2005 | 87 | 0.330 |
Why?
|
| Pain Measurement | 9 | 2005 | 358 | 0.320 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 1816 | 0.310 |
Why?
|
| Isoenzymes | 3 | 2003 | 229 | 0.300 |
Why?
|
| Gynecologic Surgical Procedures | 2 | 2005 | 63 | 0.280 |
Why?
|
| Double-Blind Method | 8 | 2022 | 1637 | 0.260 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2004 | 307 | 0.240 |
Why?
|
| Demography | 2 | 2024 | 240 | 0.220 |
Why?
|
| Tooth Extraction | 1 | 2003 | 5 | 0.220 |
Why?
|
| Emigration and Immigration | 1 | 2024 | 81 | 0.220 |
Why?
|
| Injections, Intravenous | 5 | 2003 | 255 | 0.210 |
Why?
|
| Papaverine | 1 | 2022 | 2 | 0.200 |
Why?
|
| Analgesics, Opioid | 2 | 2005 | 410 | 0.200 |
Why?
|
| Knee Joint | 1 | 2002 | 160 | 0.180 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2003 | 97 | 0.180 |
Why?
|
| Haiti | 1 | 2020 | 11 | 0.180 |
Why?
|
| Volunteers | 1 | 2020 | 25 | 0.170 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2002 | 128 | 0.170 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 4 | 2005 | 61 | 0.130 |
Why?
|
| Surgeons | 1 | 2020 | 255 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 4 | 2005 | 159 | 0.130 |
Why?
|
| Pediatrics | 1 | 2024 | 1155 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2022 | 6139 | 0.110 |
Why?
|
| Child | 3 | 2024 | 24463 | 0.110 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2022 | 1115 | 0.110 |
Why?
|
| Humans | 13 | 2024 | 124822 | 0.100 |
Why?
|
| Analgesia | 2 | 2003 | 45 | 0.100 |
Why?
|
| Hysterectomy | 2 | 2004 | 192 | 0.100 |
Why?
|
| Sulfonamides | 2 | 2003 | 264 | 0.090 |
Why?
|
| Membrane Proteins | 4 | 2005 | 1527 | 0.080 |
Why?
|
| Female | 10 | 2020 | 66580 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 1692 | 0.080 |
Why?
|
| United States | 1 | 2024 | 10876 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2020 | 12342 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8189 | 0.070 |
Why?
|
| Middle Aged | 8 | 2005 | 26730 | 0.070 |
Why?
|
| Analgesia, Patient-Controlled | 2 | 2003 | 19 | 0.070 |
Why?
|
| Postoperative Period | 2 | 2004 | 334 | 0.070 |
Why?
|
| Safety | 2 | 2003 | 219 | 0.060 |
Why?
|
| Male | 7 | 2020 | 61314 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2004 | 1017 | 0.060 |
Why?
|
| Aged | 6 | 2004 | 19697 | 0.060 |
Why?
|
| Molar, Third | 1 | 2003 | 2 | 0.060 |
Why?
|
| Laparotomy | 1 | 2004 | 135 | 0.050 |
Why?
|
| Prodrugs | 1 | 2003 | 59 | 0.050 |
Why?
|
| Coronary Artery Bypass | 2 | 2004 | 514 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2020 | 16296 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 87 | 0.050 |
Why?
|
| Adult | 5 | 2005 | 29484 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2004 | 2043 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 731 | 0.040 |
Why?
|
| Heparin | 1 | 2022 | 229 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2003 | 1499 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2005 | 487 | 0.040 |
Why?
|
| Time Factors | 3 | 2004 | 6312 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2005 | 196 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 683 | 0.010 |
Why?
|
| Psychometrics | 1 | 2004 | 676 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 1162 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 2883 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2004 | 5156 | 0.010 |
Why?
|